313
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines

, , , , , , , , & ORCID Icon show all
Pages 19-43 | Received 21 Sep 2019, Accepted 11 Dec 2019, Published online: 26 Jan 2020

References

  • Appiah-Opong R, Tuffour I, Ofori-Attah E, Aning A, Atchoglo P, Danso EA, Ahedor B, Adjei S, Nyarko AK. 2018. In vivo modulation of rat liver microsomal cytochrome p450 activity by antimalarial, anti-HIV, and antituberculosis plant medicines. J Evid Based Integr Med. 23:2515690X18810001.
  • Ayeleso TB, Matumba MG, Mukwevho E. 2017. Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases. Molecules. 22(11):1915.
  • Bala V, Rao S, Bateman E, Keefe D, Wang S, Prestidge CA. 2016. Enabling oral SN38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery system. Mol Pharm. 13(10):3518–3525.
  • Ben-Azu B, Aderibigbe AO, Ajayi AM, Eneni AO, Omogbiya IA, Owoeye O, Umukoro S, Iwalewa EO. 2019. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia. Int Immunopharmacol. 70:338–353.
  • Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, Mashru R. 2018. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: enhanced loading efficiency and its pharmacokinetic evaluation. Int J Pharm. 536(1):95–107.
  • Bilia AR, Piazzini V, Guccione C, Risaliti L, Asprea M, Capecchi G, Bergonzi MC. 2017. Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med. 83:366–381.
  • Bugel SM, Tanguay RL. 2018. Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish. Toxicol Appl Pharmacol. 344:23–34.
  • Cai SA, Hou N, Zhao GJ, Liu XW, He YY, Liu HL, Hua YQ, Li LR, Huang Y, Ou CW, et al. 2018. Nrf2 Is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats. Front Pharmacol. 9:540.
  • Chen SH, Wang XL, Zheng LZ, Dai Y, Zhang JY, Guo BL, Yang ZJ, Yao XS, Qin L. 2016. Comparative study of two types of herbal capsules with different epimedium species for the prevention of ovariectomised-induced osteoporosis in rats. J Orthop Translat. 4:14–27.
  • Chen X, Yu J, Shi J. 2018. Management of diabetes mellitus with puerarin, a natural isoflavone from Pueraria lobata. Am J Chin Med. 46(08):1771–1789.
  • Chen Y, Zhang W, Huang Y, Gao F, Fang X. 2015. Dual-functional c(RGDyK)-decorated pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor. Int J Nanomed. 10:4863–4881.
  • Chiu YH, Hsu SH, Hsu HW, Huang KC, Liu W, Wu CY, Huang WP, Chen J, Chen BH, Chiu CC. 2018. Human nonsmall cell lung cancer cells can be sensitized to camptothecin by modulating autophagy. Int J Oncol. 53:1967–1979.
  • Cho E, Jung S. 2018. Biotinylated cyclooligosaccharides for paclitaxel solubilization. Molecules. 23(1):90.
  • Choi EJ, Kim GH. 2014. The antioxidant activity of daidzein metabolites, O-desmethylangolensin and equol, in HepG2 cells. Mol Med Rep. 9(1):328–332.
  • Choi YA, Yoon YH, Choi K, Kwon M, Goo SH, Cha JS, Choi MK, Lee HS, Song IS. 2015. Enhanced oral bioavailability of morin administered in mixed micelle formulation with pluronic F127 and Tween80 in rats. Biol Pharm Bull. 38(2):208–217.
  • Cirri M, Maestrelli F, Mura P, Ghelardini C, Di Cesare Mannelli L. 2018. Combined approach of cyclodextrin complexation and nanostructured lipid carriers for the development of a pediatric liquid oral dosage form of hydrochlorothiazide. Pharmaceutics. 10(4):287.
  • Cragg G, Newman D. 2014. Natural products and drug discovery and development: a history of success and continuing promise for the future. Planta Med. 80(10):750.
  • Cross DJ, Meabon JS, Cline MM, Richards TL, Stump AJ, Cross CG, Minoshima S, Bank WA, Cook DG. 2019. Paclitaxel reduces brain injury from repeated head trauma in mice. J Alzheimers Dis. 67(3):859–874.
  • Cui Y, Mo Y, Zhang Q, Tian W, Xue Y, Bai J, Du SY. 2018. Microneedle-assisted percutaneous delivery of paeoniflorin-loaded ethosomes. Molecules. 23(12):3371.
  • Cui L, Sune E, Song J, Wang J, Jia XB, Zhang ZH. 2016. Characterization and bioavailability study of baicalin-mesoporous carbon nanopowder solid dispersion. Pharmacogn Mag. 12(48):326–332.
  • D’Addio SM, Rk P. 2011. Controlling drug nanoparticle formation by rapid precipitation. Adv Drug Deliv Rev. 63:417–426.
  • Du Y, Zhang W, He R, Ismail M, Ling L, Yao C, Fu ZL, Li XS. 2017. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Bioorg Med Chem. 25(12):3247–3258.
  • Elnaggar YS, Shehata EM, Galal S, Abdallah OY. 2017. Self-emulsifying preconcentrates of daidzein-phospholipid complex: design, in vitro and in vivo appraisal. Nanomedicine (Lond). 12(8):893–910.
  • Fong SYK, Liu M, Wei H, Löbenberg R, Kanfer I, Lee VHL, Amidon GL, Zuo Z. 2013. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification. Mol Pharm. 10(5):1623–1643.
  • Francis S, Croft D, Schüttelkopf AW, Parry C, Pugliese A, Cameron K, Claydon S, Drysdale M, Gardner C, Gohlke A, et al. 2019. Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg Med Chem Lett. 29(8):1023–1029.
  • Ganta S, Singh A, Rawal Y, Cacaccio J, Patel NR, Kulkarni P, Ferris CF, Amiji MM, Coleman TP. 2016. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer. Drug Deliv. 23(3):968–980.
  • Ganta S, Talekar M, Singh A, Coleman TP, Amiji MM. 2014. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech. 15(3):694–708.
  • Gao B, Shi HL, Li X, Qiu SP, Wu H, Zhang BB, Wu XJ, Wang ZT. 2014. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells. Life Sci. 108(2):63–70.
  • Ghadi R, Dand N. 2017. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 248:71–95.
  • Han YW, Liu XJ, Zhao Y, Li XM. 2018. Role of oleanolic acid in maintaining BBB integrity by targeting p38MAPK/VEGF/Src signaling pathway in rat model of subarachnoid hemorrhage. Eur J Pharmacol. 839:12–20.
  • Harshita Barkat MA, Rizwanullah M, Beg S, Pottoo FH, Siddiqui S, Ahmad FJ. 2019. Paclitaxel-loaded nanolipidic carriers with improved oral bioavailability and anticancer activity against human liver carcinoma. AAPS PharmSciTech. 20:87.
  • Hengjumrut P, Anukunwithaya T, Tantisira MH, Tantisira B, Khemawoot P. 2018. Comparative pharmacokinetics between madecassoside and asiaticoside presented in a standardised extract of Centella asiatica, ECa 233 and their respective pure compound given separately in rats. Xenobiotica. 48(1):18–27.
  • Henrici RC, Sutherland CJ. 2018. Alternative pathway to reduced artemisinin susceptibility in plasmodium falciparum. Proc Natl Acad Sci U S A. 115(50):12556–12558.
  • Hua F, Li CH, Chen XG, Liu XP. 2018. Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade. Int J Mol Med. 41:3485–3492.
  • Huarte J, Espuelas S, Lai YS, He B, Tang J, Irache JM. 2016. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles. Int J Pharm. 506(1–2):116–128.
  • Ideno Y, Hayashi K, Nakajima-Shimada J, Onizuka Y, Kishi M, Ueno T, Uchiyama S, Shimosawa T. 2018. Optimal cut-off value for equol-producing status in women: the Japan nurses’ health study urinary isoflavone concentration survey. PLoS One. 13(7):e0201318.
  • Jia Y, Harmon DL, Flythe MD, Klotz JL. 2015. Interaction of isoflavones and endophyte-infected tall fescue seed extract on vasoactivity of bovine mesenteric vasculature. Front Nutr. 2:32.
  • Jia SL, Wu XL, Li XX, Dai XL, Gao ZL, Lu Z, Zheng QS, Sun YX. 2016. Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-beta1-42 oligomers injected into the hippocampus. J Asian Nat Prod Res. 18(12):1186–1199.
  • Jia MQ, Xiong YJ, Xue Y, Wang Y, Yan C. 2017. Using UPLC–MS/MS for characterization of active components in extracts of Yupingfeng and application to a comparative pharmacokinetic study in rat plasma after oral administration. Molecules. 22(5):810.
  • Jiang Z, Cao Q, Dai G, Wang J, Liu C, Lv L, Pan JH. 2019. Celastrol inhibits colorectal cancer through TGF-beta1/Smad signaling. Onco Targets Ther. 12:509–518.
  • Jiang QW, Cheng KJ, Mei XL, Qiu JG, Zhang WJ, Xue YQ, Qin WM, Yang Y, Zheng DW, Chen Y, et al. 2015. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget. 6(32):32790–32804.
  • Jiang Z, Jiang X, Li C, Xue H, Zhang X. 2016. Development of an IgY antibody-based immunoassay for the screening of the CYP2E1 inhibitor/enhancer from herbal medicines. Front Pharmacol. 7:502.
  • Jiang YR, Zhang ZH, Liu QY, Hu SY, Chen XY, Jia XB. 2013. Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles. Int J Nanomed. 8:2285–2293.
  • Jin X, Asghar S, Zhu XT, Chen ZP, Liu JH, Li YB, Li H, Ping Q, Xiao Y. 2017. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Drug Dev Ind Pharm. 43(10):1637–1647.
  • Ju Y, Su Y, Chen Q, Ma K, Ji T, Wang Z, Li W, Li WP. 2019. Protective effects of astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats. Biomed Pharmacother. 109:84–92.
  • Jung Y, Jerng U, Lee S. 2016. A systematic review of anticancer effects of radix astragali. Chin J Integr Med. 22(3):225–236.
  • Kaeferstein H. 2009. Forensic relevance of glucuronidation in phase-II-metabolism of alcohols and drugs. Legal Med. 11:22–26.
  • Kawatani M, Muroi M, Wada A, Inoue G, Futamura Y, Aono H, Shimizu K, Shimizu T, Igarashi Y, Takahashi-Aono N, et al. 2016. Proteomic profiling reveals that collismycin A is an iron chelator. Sci Rep. 6(1):38385.
  • Khurana RK, Bansal AK, Beg S, Burrow AJ, Katare OP, Singh KK, Singh B. 2017. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm. 518(1–2):289–306.
  • Khurana RK, Gaspar BL, Welsby G, Katare OP, Singh KK, Singh B. 2018. Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phospholipidic nano-mixed micellar systems. Drug Deliv Transl Res. 8(3):617–632.
  • Le A, Wang ZH, Dai XY, Xiao TH, Zhuo R, Zhang B, Xiao Z, Fan X. 2017. Icaritin inhibits decidualization of endometrial stromal cells. Exp Ther Med. 14:5949–5955.
  • Li Z, Li Y, Li J, Liu R, Hao J, He J, Cao J, Chang Y. 2019. An LC–MS/MS method for simultaneous determination of the toxic and active components of cortex periplocae in rat plasma and application to a pharmacokinetic study. Int J Anal Chem. 2019:1–10.
  • Li X, Lin Y, Zhou H, Li Y, Wang A, Wang H, Zhou M. 2017. Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension. Clin Exp Hypertens. 39(1):58–64.
  • Li R, Niosi M, Johnson N, Tess DA, Kimoto E, Lin J, Yang X, Riccardi KA, Ryu S, Ei-Kattan AF, et al. 2018. A study on pharmacokinetics of bosentan with systems modeling, part 1: translating systemic plasma concentration to liver exposure in healthy subjects. Drug Metab Dispos. 46(4):346–356.
  • Li L, Yin H, Zhao Y, Zhang X, Duan C, Liu J, Huang C, Liu S, Yang S, Li X. 2018. Protective role of puerarin on LPS/D-Gal induced acute liver injury via restoring autophagy. Am J Transl Res. 10(3):957–965.
  • Liu C, Fan H, Li Y, Xiao X. 2016. Research advances on hepatotoxicity of herbal medicines in China. Biomed Res Int. 2016:7150391.
  • Liu Y, Luo X, Xu X, Gao N, Liu X. 2017. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes. Int J Pharm. 517(1–2):1–7.
  • Lokova AY, Zaborova OV. 2019. Modification of fliposomes with a polycation can enhance the control of pH-induced release. Int J Nanomedicine. 14:1039–1049.
  • Ludden TM. 1991. Nonlinear pharmacokinetics: clinical implications. Clin Pharmacokinet. 20(6):429–446.
  • Ly TTB, Schifrin A, Nguyen BD, Bernhardt R. 2017. Improvement of a p450-based recombinant Escherichia coli whole-cell system for the production of oxygenated sesquiterpene derivatives. J Agric Food Chem. 65(19):3891–3899.
  • Maier-Salamon A, Thalhammer T, Reznicek G, Böhmdorfer M, Zupkó I, Hartl A, Jaeger W. 2014. Cytochrome P450 3A-mediated metabolism of the topoisomerase I inhibitor 9-aminocamptothecin: impact on cancer therapy. Int J Oncol. 45(2):877–886.
  • Mandal D, Shaw TK, Dey G, Pal MM, Mukherjee B, Bandyopadhyay AK, Mandal M. 2018. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles – a possibility for hepatic drug targeting: pharmacokinetics and biodistribution. Int J Biol Macromol. 112:818–830.
  • Muriana FJG, Montserrat-de la Paz S, Lucas R, Bermudez B, Jaramillo S, Morales JC, Abia R, Lopez S. 2017. Tyrosol and its metabolites as antioxidative and anti-inflammatory molecules in human endothelial cells. Food Funct. 8:2905–2914.
  • Ni XJ, Xu ZQ, Jin H, Zheng SL, Cai Y, Wang JJ. 2017. Ginsenoside Rg1 protects human renal tubular epithelial cells from lipopolysaccharide-induced apoptosis and inflammation damage. Braz J Med Biol Res. 51(2):e6611.
  • Ogawa-Ochiai K, Kawasaki K. 2018. Panax ginseng for frailty-related disorders: a review. Front Nutr. 5:140.
  • Piao L, Li Y, Zhang H, Jiang J. 2019. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model. J Biomater Sci Polym Ed. 30(3):233–246.
  • Qi X, Qin J, Ma N, Chou X, Wu Z. 2014. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, characterization and bioavailability evaluation. Int J Pharm. 472(1–2):40–47.
  • Ran RX, Zhang CZ, Li RS, Chen BW, Zhang WH, Zhao ZY, Fu XL, Du Z, Du XL, Yang XL, et al. 2016. Evaluation and comparison of the inhibition effect of astragaloside IV and aglycone cycloastragenol on various UDP-glucuronosyltransferase (UGT) isoforms. Molecules. 21(12):1616.
  • Ren X, Qi J, Wu W, Yin Z, Li T, Lu Y. 2019. Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation. Acta Pharm Sin B. 9(1):118–127.
  • Saito K, Davis KC, Morgan DA, Toth BA, Jiang J, Singh U, Berglund ED, Grobe JL, Rahmouni K, Cui H. 2019. Celastrol reduces obesity in mc4r deficiency and stimulates sympathetic nerve activity affecting metabolic and cardiovascular functions. Diabetes. 68(6):1210–1220.
  • Shah VP, Amidon GL. 2014. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413–420, 1995—backstory of BCS. AAPS J. 16(5):894–898.
  • Shang Z, Xin Q, Zhao W, Wang Z, Li Q, Zhang J, Cong W. 2017. Rapid profiling and identification of puerarin metabolites in rat urine and plasma after oral administration by UHPLC-LTQ-Orbitrap mass spectrometer. J Chromatogr B. 1068–1069:180–192.
  • Shao YP, Zhang W, Tong L, Huang JY, Li DX, Nie W, Zhu Y, Li YF, Lu T. 2017. Simultaneous determination of eight bioactive components of Qishen Yiqi dripping pills in rat plasma using UFLC–MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 31(8):e3941.
  • Shen J, Li N, Zhang X. 2019. Daidzein ameliorates dextran sulfate sodium-induced experimental colitis in mice by regulating NF-kappab signaling. J Environ Pathol Toxicol Oncol. 38(1):29–39.
  • Shi PY, Lin XH, Yao H. 2018. A comprehensive review of recent studies on pharmacokinetics of traditional Chinese medicines (2014–2017) and perspectives. Drug Metab Rev. 2:161–192.
  • Shimizu Y, Tamada S, Kato M, Hirayama Y, Takeyama Y, Iguchi T, Sadar M, Nakatani T. 2018. Androgen receptor splice variant 7 drives the growth of castration resistant prostate cancer without being involved in the efficacy of taxane chemotherapy. J Clin Med. 7(11):444.
  • Song X, Bai XH, Liu SY, Dong LJ, Deng H, Wang CL. 2016. A novel microspheres formulation of puerarin: pharmacokinetics study and in vivo pharmacodynamics evaluations. Evid Based Compl Alternat Med. 2016:4016963.
  • Song D, Jiang X, Liu Y, Sun Y, Cao S, Zhang Z. 2018. Asiaticoside attenuates cell growth inhibition and apoptosis induced by Aβ1-42 via inhibiting the TLR4/NF-κB signaling pathway in human brain microvascular endothelial cells. Front Pharmacol. 9:28.
  • Sudirman S, Hsu YH, Johnson A, Tsou D, Kong ZL. 2018. Amelioration effects of nanoencapsulated triterpenoids from petri dish-cultured Antrodia cinnamomea on reproductive function of diabetic male rats. Int J Nanomedicine. 13:5059–5073.
  • Sun B, Dai G, Bai Y, Zhang W, Zhu L, Chu J, Pan R, Ju W. 2017. Determination of paeoniflorin in rat plasma by ultra-high performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study. J Chromatogr Sci. 55(10):1006–1012.
  • Sun X, Deng X, Cai W, Li W, Shen Z, Jiang T, Huang J. 2018. Icariin inhibits LPS-induced cell inflammatory response by promoting GRα nuclear translocation and upregulating GRα expression. Life Sci. 195:33–43.
  • Tabanor K, Lee P, Kiptoo P, Choi IY, Sherry EB, Eagle CS, Williams T, Siahaan T. 2016. Brain delivery of drug and MRI contrast agent: detection and quantitative determination of brain deposition of CPT-Glu using LC–MS/MS and Gd-DTPA using magnetic resonance imaging. Mol Pharm. 13(2):379–390.
  • Tang B, Zhang JG, Tan HY, Wei XQ. 2018. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure. Biosci Rep. 38.
  • Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, Zhang M, Zhao X, Shen J, Wu S, et al. 2018. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. MBio. 9(3):e02392–e02317.
  • Tu L, Wang Y, Chen D, Xiang P, Shen J, Li Y, Wang SL. 2018. Protective effects of notoginsenoside R1 via regulation of the PI3K-Akt-mTOR/JNK pathway in neonatal cerebral hypoxic-ischemic brain injury. Neurochem Res. 43(6):1210–1226.
  • Venkatesha SH, Dudics S, Astry B, Moudgil KD. 2016. Control of autoimmune inflammation by celastrol, a natural triterpenoid. Pathog Dis. 74(6):ftw059.
  • Vinayagam R, Xiao JB, Xu BJ. 2017. An insight into anti-diabetic properties of dietary phytochemicals. Phytochem Rev. 16(3):535–553.
  • Wang B, Dai W, Shi L, Teng H, Li X, Wang J, Geng W. 2018a. Neuroprotection by paeoniflorin against nuclear factor kappa B-induced neuroinflammation on spinal cord injury. Biomed Res Int. 2018:9865403.
  • Wang L, Hong XD, Yao ZH, Dai Y, Zhao GP, Qin ZF, Wu B, Gonzalez F, Yao X. 2018b. Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes. Xenobiotica. 48(4):357–367.
  • Wang Q, Huang J, Hu C, Xia N, Li T, Xia Q. 2017a. Stabilization of a non-aqueous self-double-emulsifying delivery system of rutin by fat crystals and nonionic surfactants: preparation and bioavailability study. Food Funct. 8(7):2512–2522.
  • Wang Z, Huang C, Yang JJ, Song Y, Cheng Y, Chen GY, Yan HH, Ben XS, Wang BC, Xu CR, et al. 2019. A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). Eur J Cancer. 109:183–191.
  • Wang Y, Miao X, Sun L, Song J, Bi C, Yang X, Zheng Y. 2014. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs. Curr Pharm Des. 20(3):454–473.
  • Wang XF, Wang J. 2014. Icaritin suppresses the proliferation of human osteosarcoma cells in vitro by increasing apoptosis and decreasing MMP expression. Acta Pharmacol Sin. 35(4):531–539.
  • Wang XB, Wang W, Zhu XC, Ye WJ, Cai H, Wu PL, Huang XY, Wang LX. 2015. The potential of asiaticoside for TGF-beta1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension. Life Sci. 137:56–64.
  • Wang FR, Zhang Y, Yang XB, Liu CX, Yang XW, Xu W, Liu JX. 2017b. Rapid determination of 30 polyphenols in Tongmai formula, a combination of Puerariae Lobatae Radix, Salviae Miltiorrhizae Radix et Rhizoma, and Chuanxiong Rhizoma, via liquid chromatography–tandem mass spectrometry. Molecules. 22(4):545.
  • Wang JL, Zhao F, Liu R, Chen JJ, Zhang QH, Lao RJ, Wang Z, Jin X, Liu C. 2017c. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies. Int J Nanomedicine. 12:8115–8127.
  • Wang Q, Zhu R, Wang M, Xing S, Li L, He Y, Cao W, Gao D. 2017d. Targeted therapy of octreotide-modified oleanolic acid liposomes to somatostatin receptor overexpressing tumor cells. Nanomedicine (Lond). 12(8):927–940.
  • Wei Y, Guo J, Zheng X, Wu J, Zhou Y, Yu Y, Ye Y, Zhang L, Zhao L. 2014. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. Int J Nanomed. 9:3623–3630.
  • Wei F, Jiang X, Gao HY, Gao SH. 2017. Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo. Int J Oncol. 51(5):1383–1394.
  • Wei Y, Zhou X, Ren L, Wang C, Li Y. 2018. The prolactin-release inhibitor paeoniflorin suppresses proliferation and induces apoptosis in prolactinoma cells via the mitochondria-dependent pathway. J Cell Biochem. 119(7):5704–5714.
  • Wu L, Bi Y, Wu H. 2018. Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure. Drug Dev Ind Pharm. 44(2):266–275.
  • Wu H, Long X, Yuan F, Chen L, Pan S, Liu Y, Stowell Y, Li XL. 2014. Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin. Acta Pharm Sin B. 4(3):217–226.
  • Wu C, Zhang Y, Yang DQ, Zhang JF, Ma JJ, Cheng D, Chen JM, Deng L. 2019. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study. Int J Nanomedicine. 14:75–85.
  • Xi JS, Wang YF, Long XX, Ma Y. 2018. Mangiferin potentiates neuroprotection by isoflurane in neonatal hypoxic brain injury by reducing oxidative stress and activation of phosphatidylinositol-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling. Med Sci Monit. 24:7459–7468.
  • Xia X, Liu H, Lv H, Zhang J, Zhou J, Zhao Z. 2017. Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles. Drug Des Devel Ther. 11:1417–1427.
  • Xie F, De Thaye E, Vermeulen A, Van Bocxlaer J, Colin P. 2018a. A dried blood spot assay for paclitaxel and its metabolites. J Pharm Biomed Anal. 148:307–315.
  • Xie YY, Wang XM, Wang SH, Wang YM, Tian HF, Yuan YS, Li HY, Liang QL, Guo L. 2016. Metabolism and pharmacokinetics of major polyphenol components in rat plasma after oral administration of total flavonoid tablet from Anemarrhenae Rhizoma. J Chromatogr B. 1026:134–144.
  • Xie Y, Zhou X, Pei H, Chen MC, Sun ZL, Xue YR, Tian XT, Huang CG. 2018b. Metabolism, pharmacokinetics, and hepatic disposition of xanthones and saponins on Zhimu treatments for exploratively interpreting the discrepancy between the herbal safety and timosaponin A3-induced hepatotoxicity. Acta Pharmacol Sin. 39(12):1923–1934.
  • Xu TZ, Shen XY, Sun LL, Chen YL, Zhang BQ, Huang DK, Li WZ. 2019. Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro. Int J Mol Med. 43:717–726.
  • Xu JJ, Xu BH, Shou D, Qin FH, Xu Y, Hu Y. 2016. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system. Eur J Pharm Sci. 83:132–142.
  • Xu S, Yu J, Zhan J, Yang L, Guo L, Xu Y. 2017. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. Biomed Res Int. 2017:4684962.
  • Yan S, Liu Y, Feng J, Zhao H, Yu Z, Zhao J, Li Y, Zhang JQ. 2018. Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines. Drug Metab Rev. 50(2):140–160.
  • Yang EJ, Kim TH, Shin KC, Oh DK. 2018. Complete conversion of all typical glycosylated protopanaxatriol ginsenosides to aglycon protopanaxatriol by combined bacterial beta-glycosidases. AMB Expr. 8(1):8.
  • Yang X, Miao XQ, Cao FR, Li S, Ai NN, Chang Q, Lee S, Zheng Y. 2014. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin. J Pharm Sci. 103(11):3576–3584.
  • Yin X, Daintree LS, Ding S, Ledger DM, Wang B, Zhao W, Qi J, Wu W, Han J. 2015. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Drug Des Devel Ther. 9:2801–2810.
  • Zeng JK, Li YY, Wang TM, Zhong J, Wu JS, Liu P, Zhang H, Ma YM. 2018. Simultaneous quantification of multiple components in rat plasma by UPLC–MS/MS and pharmacokinetic study after oral administration of Huangqi decoction. Biomed Chromatogr. 32(5):e4178.
  • Zeng X, Su W, Zheng Y, He Y, He Y, Rao H, Peng W, Hong L. 2019. Pharmacokinetics, tissue distribution, metabolism, and excretion of naringin in aged rats. Front Pharmacol. 10:34.
  • Zeng M, Yang L, He D, Li Y, Shi M, Zhang J. 2017. Metabolic pathways and pharmacokinetics of natural medicines with low permeability. Drug Metab Rev. 49(4):464–476.
  • Zhan H, Liang JF. 2017. Preparation and anticancer activity evaluation of an amorphous drug nanocomposite by simple heat treatment. Anticancer Drugs. 28(6):623–633.
  • Zhang J, Ding L, Wang B, Ren G, Sun A, Deng C, Wei X, Mani S, Wang Z, Dou W. 2015. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane x receptor activation. J Pharmacol Exp Ther. 352(2):315–324.
  • Zhang J, Li Y, Fang X, Zhou D, Wang Y, Chen M. 2014a. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIa delivery in cancer therapy. Int J Pharm. 476(1–2):185–198.
  • Zhang YQ, Tian DL, Huang YY, Li L, Mao J, Tian J, Ding J. 2016a. Pharmacokinetic evaluation of Shenfu injection in beagle dogs after intravenous drip administration. Acta Pharm Sin B. 6(6):584–592.
  • Zhang H, Wang X, Dai W, Gemeinhart RA, Zhang Q, Li T. 2014b. Pharmacokinetics and treatment efficacy of camptothecin nanocrystals on lung metastasis. Mol Pharm. 11(1):226–233.
  • Zhang Y, Wang C, Yang F, Sun G. 2019a. A strategy for qualitative and quantitative profiling of glycyrrhiza extract and discovery of potential markers by fingerprint-activity relationship modeling. Sci Rep. 9(1):1309.
  • Zhang B, Xue A, Zhang C, Yu J, Chen W, Sun D. 2016b. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel. Pharmazie. 71(6):320–326.
  • Zhang HQ, Yang XY, Zhao LL, Jiao Y, Liu JY, Zhai GX. 2016c. In vitro and in vivo study of baicalin-loaded mixed micelles for oral delivery. Drug Deliv. 23:1933–1939.
  • Zhang J, Zhang J, Wang S, Yi T. 2018. Development of an oral compound pickering emulsion composed of nanocrystals of poorly soluble ingredient and volatile oils from traditional Chinese medicine. Pharmaceutics. 10(4):170.
  • Zhang B, Zhang X, Zhang C, Shen Q, Sun G, Sun X. 2019b. Notoginsenoside R1 protects db/db mice against diabetic nephropathy via upregulation of Nrf2-mediated HO-1 expression. Molecules. 24(2):247.
  • Zhao C, Cao W, Zheng H, Xiao Z, Hu J, Yang L, Chen M, Liang G, Zheng S, Zhao C. 2019. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer. Int J Nanomedicine. 14:1597–1618.
  • Zhao H, Jiang Z, Chang X, Xue H, Yahefu W, Zhang X. 2018. 4-Hydroxyphenylacetic acid prevents acute APAP-induced liver injury by increasing phase II and antioxidant enzymes in mice. Front Pharmacol. 9:653.
  • Zhao YZ, Zhang L, Gupta PK, Tian FR, Mao KL, Qiu KY, Yang W, Lv C, Lu C. 2016. Using PG-liposome-based system to enhance puerarin liver-targeted therapy for alcohol-induced liver disease. AAPS PharmSciTech. 17(6):1376–1382.
  • Zheng Y, Lu L, Yan Z, Jiang S, Yang S, Zhang Y, Xu K, He C, Tao XJ, Zhang QF. 2019. mPEG-icariin nanoparticles for treating myocardial ischaemia. Artif Cells Nanomed Biotechnol. 47(1):801–811.
  • Zheng S, Zhang Y, Qiao Y. 2015. The mechanism research of Qishen Yiqi formula by module-network analysis. Evid Based Compl Alternat Med. 2015:497314.
  • Zheng T, Zhang TB, Wang CL, Zhang WX, Jia DH, Yang F, Sun YY, Ding X, Wang R. 2018. Icariside II promotes the differentiation of adipose tissue-derived stem cells to Schwann cells to preserve erectile function after cavernous nerve injury. Mol Cells. 41(6):553–561.
  • Zhou Y, Song X, Dong G. 2019. Effects of verapamil on the pharmacokinetics of puerarin in rats. Xenobiotica. 49(10):1178–1182.
  • Zhu L, Li D, Chen C, Wang G, Shi J, Zhang F. 2019. Activation of Nrf2 signaling by icariin protects against 6-OHDA-induced neurotoxicity. Biotechnol Appl Biochem. 66(3):465–471.
  • Zhu H, Wang X, Han Y, Zhang W, Xin W, Zheng X, Zhang J. 2018. Icariin promotes the migration of bone marrow stromal cells via the SDF-1α/HIF-1α/CXCR4 pathway. Drug Des Devel Ther. 12:4023–4031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.